publication venue for
- Single-cell transcriptomics reveals targeted modulation of inflammatory repertoire by SOCE blockers.. 87. 2026
- A glance at the geographical distribution of histocompatibility laboratories. 2025
- Blockade of store-operated calcium entry by BTP2 preserves anti-inflammatory gene expression in human peripheral blood mononuclear cells.. 85. 2024
- Unbalanced T-cell subsets in pediatric patients with beta-thalassemia.. 84. 2023
- FOXP3+/CD68+ ratio within the tumor microenvironment may serve as a potential prognostic factor in classical Hodgkin lymphoma.. 83. 2022
- Hyperglycemia and dyslipidemia: Reduced HLA-DR expression in monocyte subpopulations from diabetes patients.. 82. 2020
- Increased access to transplantation of highly sensitized patients under the new kidney allocation system. A single center experience.. 78. 2016
- Psoriasis risk SNPs and their association with HIV-1 control.. 78. 2016
- Impairment of the humoral and CD4(+) T cell responses in HTLV-1-infected individuals immunized with tetanus toxoid.. 77. 2016
- FASL-844 T/C polymorphism: a biomarker of good prognosis of breast cancer in the Tunisian population.. 73. 2012
- Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome.. 72. 2010
- Gene expression profiling of the donor kidney at the time of transplantation predicts clinical outcomes 2 years after transplantation.. 71. 2010
- Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.. 71. 2010
- Peripheral blood mononuclear cell transcriptome profiles suggest T-cell immunosuppression after uncomplicated mechanical circulatory support device surgery.. 71. 2009
- Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages.. 70. 2009
- Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity.. 70. 2009
- Circulating HLA-DR(+) natural killer cells have potent lytic ability and weak antigen-presenting cell function.. 69. 2008
- Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma.. 68. 2007
- Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages.. 68. 2007
- Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma.. 67. 2006
- Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris.. 67. 2005
- Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.. 64. 2003
- Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system.. 64. 2003
- Blood dendritic cells and DC-poietins in systemic lupus erythematosus.. 63. 2002
- Functional properties of lymphocytes in idiopathic thrombocytopenic purpura.. 62. 2001
- Association analysis of HLA-class II and class III gene polymorphisms in the susceptibility to mediterranean visceral leishmaniasis.. 62. 2001
- Soluble HLA proteins with bound peptides are released from the cell surface by the membrane metalloproteinase.. 61. 2000
- A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells.. 61. 2000
- Peptide-conformed beta2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinase.. 60. 1999
- The metalloproteinase-mediated pathway is essential for generation of soluble HLA class I proteins by activated cells in vitro: proposed mechanism for soluble HLA release in transplant rejection.. 59. 1998
- Allelic variants of human TCR BV17S1 defined by restriction fragment length polymorphism, single strand conformation polymorphism, and amplification refractory mutation system analyses.. 49. 1996
- Restoration of CD2-mediated signaling by a chimeric membrane protein including the cytoplasmic sequence of CD45.. 40. 1994
- Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency disease.. 29. 1990
- Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency disease.. 26. 1989
- Characterization of B cells in severe combined immunodeficiency disease.. 25. 1989
- Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients.. 25. 1989
- HLA typing used with cultured amniotic and chorionic villus cells for early prenatal diagnosis or parentage testing without one parent's availability.. 16. 1986
- Murine monoclonal antibodies as probes for the phenotypical, functional, and molecular analysis of a discrete peripheral blood lymphocyte population exerting natural killer activity in vitro.. 14. 1985
- Practical guide to personnel competency assessment in clinical histocompatibility laboratories. 2025
- Urine biomarkers informative of human kidney allograft rejection and tolerance. 2018